BioSyent Inc. (OTCMKTS:BIOYF) Sees Large Increase in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) was the target of a large growth in short interest during the month of October. As of October 31st, there was short interest totalling 1,300 shares, a growth of 18.2% from the October 15th total of 1,100 shares. Based on an average daily volume of 1,700 shares, the short-interest ratio is presently 0.8 days.

BioSyent Price Performance

BIOYF opened at $7.83 on Friday. The stock’s 50 day moving average price is $8.00 and its two-hundred day moving average price is $7.44. BioSyent has a 12-month low of $5.86 and a 12-month high of $8.90.

BioSyent Increases Dividend

The business also recently disclosed a dividend, which was paid on Sunday, September 15th. Stockholders of record on Thursday, September 5th were paid a $0.0334 dividend. This is an increase from BioSyent’s previous dividend of $0.03. The ex-dividend date was Wednesday, September 4th. This represents a dividend yield of 1.72%.

BioSyent Company Profile

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.